Lenalidomide in Treating Patients With High Risk Acute Myeloid Leukemia in Remission
Conditions
- Alkylating Agent-Related Acute Myeloid Leukemia
- Secondary Acute Myeloid Leukemia
Interventions
- OTHER: Laboratory Biomarker Analysis
- DRUG: Lenalidomide
Sponsor
M.D. Anderson Cancer Center
Collaborators